A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants
Clinical trial NCT06212804 · COMPLETED
Trial details
- NCT number
- NCT06212804
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2024-07-19
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.